(Q43849185)

27 November 2017

Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease (English)

1 reference

27 November 2017

0 references

Wigfall DR

1

1 reference

27 November 2017

Ware RE

2

1 reference

27 November 2017

Burchinal MR

3

1 reference

27 November 2017

Kinney TR

4

1 reference

27 November 2017

Foreman JW

5

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

The Journal of Pediatrics

27 November 2017

1 reference

27 November 2017

136

1 reference

27 November 2017

6

1 reference

27 November 2017

749-753

1 reference

Prognosis of the nephrotic syndrome in sickle glomerulopathy. A retrospective study

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

Survival analysis by sex, age group and hemotype in sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

Causes of death in sickle-cell disease in Jamaica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

National study on natural history of renal allografts in sickle cell disease or trait

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

Raised erythropoietin and thrombotic events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

Renal transplantation in sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

Recurrent sickle cell nephropathy in a transplanted kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

Beta-2-microglobulin in sickle cell anaemia. Evidence of increased tubular reabsorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

Sickle-cell disease and poststreptococcal acute glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

Cryoprecipitable Immune Complexes, Nephropathy, and Sickle-Cell Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

Nephropathy associated with sickle cell anemia: an autologous immune complex nephritis. I. Studies on nature of glomerular-bound antibody and antigen identification in a patient with sickle cell disease and immune deposit glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

Nephropathy associated with sickle cell anemia: an autologous immune complex nephritis. II. Clinicopathologic study of seven patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

Renal lesions in sickle cell nephropathy in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

Proteinuria in sickle cell trait and disease: an electrophoretic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

A population study of renal function in sickle cell anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

Renal involvement in sickle cell-beta thalassemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

Sickle cell disease as a cause of osteonecrosis of the femoral head

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

Pain in sickle cell disease. Rates and risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

Mortality in sickle cell disease. Life expectancy and risk factors for early death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

Enalapril reduces the albuminuria of patients with sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2948828-1

10.1016/S0022-3476(00)48828-1

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference